Squarepoint’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9K Buy
+17,759
New +$19.9K ﹤0.01% 2669
2025
Q1
Sell
-34,295
Closed -$56.6K 2902
2024
Q4
$56.6K Buy
34,295
+20,805
+154% +$34.3K ﹤0.01% 2624
2024
Q3
$47.2K Sell
13,490
-115,269
-90% -$403K ﹤0.01% 2435
2024
Q2
$422K Buy
+128,759
New +$422K ﹤0.01% 1811
2024
Q1
Sell
-176,495
Closed -$660K 2577
2023
Q4
$660K Sell
176,495
-98,306
-36% -$368K ﹤0.01% 1547
2023
Q3
$583K Buy
274,801
+210,582
+328% +$446K ﹤0.01% 1548
2023
Q2
$306K Sell
64,219
-60,000
-48% -$286K ﹤0.01% 1860
2023
Q1
$708K Sell
124,219
-471,016
-79% -$2.68M ﹤0.01% 1320
2022
Q4
$6.01M Buy
+595,235
New +$6.01M 0.02% 430
2022
Q3
Sell
-13,207
Closed -$327K 2216
2022
Q2
$327K Buy
+13,207
New +$327K ﹤0.01% 1552
2022
Q1
Sell
-25,739
Closed -$1.51M 2422
2021
Q4
$1.51M Sell
25,739
-72,135
-74% -$4.22M ﹤0.01% 1008
2021
Q3
$5.8M Buy
97,874
+91,416
+1,416% +$5.42M 0.02% 442
2021
Q2
$560K Sell
6,458
-8,811
-58% -$764K ﹤0.01% 1533
2021
Q1
$1.26M Buy
+15,269
New +$1.26M 0.01% 942
2020
Q4
Sell
-12,553
Closed -$502K 2626
2020
Q3
$502K Sell
12,553
-54,026
-81% -$2.16M 0.01% 1345
2020
Q2
$2.28M Buy
66,579
+52,979
+390% +$1.82M 0.04% 581
2020
Q1
$302K Sell
13,600
-50,301
-79% -$1.12M 0.01% 1290
2019
Q4
$1.25M Sell
63,901
-103,510
-62% -$2.03M 0.01% 1174
2019
Q3
$2.6M Buy
167,411
+133,153
+389% +$2.07M 0.02% 715
2019
Q2
$695K Sell
34,258
-49,515
-59% -$1M 0.01% 1448
2019
Q1
$1.47M Buy
83,773
+64,078
+325% +$1.13M 0.02% 902
2018
Q4
$253K Sell
19,695
-35,837
-65% -$460K ﹤0.01% 1561
2018
Q3
$905K Buy
+55,532
New +$905K 0.01% 1040
2018
Q1
Sell
-11,397
Closed -$70K 1816
2017
Q4
$70K Buy
+11,397
New +$70K ﹤0.01% 1985
2017
Q3
Sell
-28,900
Closed -$94K 1667
2017
Q2
$94K Hold
28,900
﹤0.01% 1407
2017
Q1
$131K Buy
28,900
+8,900
+45% +$40.3K ﹤0.01% 1364
2016
Q4
$50K Buy
+20,000
New +$50K ﹤0.01% 1699